Engineered Nanoparticles for Drug Delivery in Cancer Therapy
The DOI matches its Crossref record; 579 of the 579 references it cites were found in a registry or an index.
Abstract
In medicine, nanotechnology has sparked a rapidly growing interest as it promises to solve a number of issues associated with conventional therapeutic agents, including their poor water solubility (at least, for most anticancer drugs), lack of targeting capability, nonspecific distribution, systemic toxicity, and low therapeutic index. Over the past several decades, remarkable progress has been made in the development and application of engineered nanoparticles to treat cancer more effectively. For example, therapeutic agents have been integrated with nanoparticles engineered with optimal sizes, shapes, and surface properties to increase their solubility, prolong their circulation half‐life, improve their biodistribution, and reduce their immunogenicity. Nanoparticles and their payloads have also been favorably delivered into tumors by taking advantage of the pathophysiological conditions, such as the enhanced permeability and retention effect, and the spatial variations in the pH value. Additionally, targeting ligands (e.g., small organic molecules, peptides, antibodies, and nucleic acids) have been added to the surface of nanoparticles to specifically target cancerous cells through selective binding to the receptors overexpressed on their surface. Furthermore, it has been demonstrated that multiple types of therapeutic drugs and/or diagnostic agents (e.g., contrast agents) could be delivered through the same carrier to enable combination therapy with a potential to overcome multidrug resistance, and real‐time readout on the treatment efficacy. It is anticipated that precisely engineered nanoparticles will emerge as the next‐generation platform for cancer therapy and many other biomedical applications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Endothelial cells, fibroblasts, and immune cells are the three main cell types which appear in most cancers and are vital components in enhancing the drug resistance of tumors [103, 114-120].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [103]
In the citing paper
“Vasculature plays an essential role in the growth and metastasis of malignant tumors [103].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [103]
In the citing paper
“Endothelial cells, fibroblasts, and immune cells are the three main cell types which appear in most cancers and are vital components in enhancing the drug resistance of tumors [103, 114-120].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [103]
Citations
Cites
Items 201–400 of 579
Assessing the In Vitro and In Vivo Toxicity of Superparamagnetic Iron Oxide Nanoparticles
Mahmoudi, M., Hofmann, H., Rothen-Rutishauser, B., & Petri-Fink, A. (2012) · Chemical Reviews · doi:10.1021/cr2002596 · Cited by 617
Shape Induced Inhibition of Phagocytosis of Polymer Particles
Champion, J. A., & Mitragotri, S. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9626-z · Cited by 617
Chung, T.-H., Wu, S.-H., Yao, M., Lu, C.-W., Lin, Y.-S., Hung, Y., Mou, C.-Y., Chen, Y.-C., & Huang, D.-M. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.03.006 · Cited by 617
Intravascular Delivery of Particulate Systems: Does Geometry Really Matter?
Decuzzi, P., Pasqualini, R., Arap, W., & Ferrari, M. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9697-x · Cited by 616
Feazell, R. P., Nakayama-Ratchford, N., Dai, H., & Lippard, S. J. (2007) · Journal of the American Chemical Society · doi:10.1021/ja073231f · Cited by 616
Thermally on-off switching polymers for drug permeation and release
Okano, T., Bae, Y. H., Jacobs, H., & Kim, S. W. (1990) · Journal of Controlled Release · doi:10.1016/0168-3659(90)90138-j · Cited by 616
Thomas, C. R., Ferris, D. P., Lee, J.-H., Choi, E., Cho, M. H., Kim, E. S., Stoddart, J. F., Shin, J.-S., Cheon, J., & Zink, J. I. (2010) · Journal of the American Chemical Society · doi:10.1021/ja1022267 · Cited by 615
Super pH-Sensitive Multifunctional Polymeric Micelle
Lee, E. S., Na, K., & Bae, Y. H. (2005) · Nano Letters · doi:10.1021/nl0479987 · Cited by 611
Perry, J. L., Reuter, K. G., Kai, M. P., Herlihy, K. P., Jones, S. W., Luft, J. C., Napier, M., Bear, J. E., & DeSimone, J. M. (2012) · Nano Letters · doi:10.1021/nl302638g · Cited by 606
Neri, D., & Bicknell, R. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1627 · Cited by 600
The Carrier Potential of Liposomes in Biology and Medicine: (First of Two Parts)
Gregoriadis, G. (1976) · New England Journal of Medicine · doi:10.1056/nejm197609232951305 · Cited by 595
Dendritic polymer macromolecular carriers for drug delivery
Patri, A. K., Majoros, I. J., & Baker, J. R. (2002) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(02)00347-2 · Cited by 595
Li, W. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.041 · Cited by 588
Garay, R. P., El-Gewely, R., Armstrong, J. K., Garratty, G., & Richette, P. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.720969 · Cited by 587
Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles
Gupta, A. K., & Gupta, M. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.05.022 · Cited by 586
Nanocages Derived from Shell Cross-Linked Micelle Templates
Huang, H., Remsen, E. E., Kowalewski, T., & Wooley, K. L. (1999) · Journal of the American Chemical Society · doi:10.1021/ja983610w · Cited by 575
Dendrimers as versatile platform in drug delivery applications
Svenson, S. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.023 · Cited by 570
The role of HER2 in cancer therapy and targeted drug delivery
Tai, W., Mahato, R., & Cheng, K. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.04.009 · Cited by 555
Nanocapsule Technology: A Review
Couvreur, P., Barratt, G., Fattal, E., & Vauthier, C. (2002) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v19.i2.10 · Cited by 555
Litzinger, D. C., Buiting, A. M. J., van Rooijen, N., & Huang, L. (1994) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)90038-8 · Cited by 546
Dendrimers: Emerging polymers for drug-delivery systems
Nanjwade, B. K., Bechra, H. M., Derkar, G. K., Manvi, F. V., & Nanjwade, V. K. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.07.008 · Cited by 542
Biopolymer-based microgels/nanogels for drug delivery applications
Oh, J. K., Lee, D. I., & Park, J. M. (2009) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2009.08.001 · Cited by 542
PEGylated PLGA nanoparticles as protein carriers: Synthesis, preparation and biodistribution in rats
Li, Y.-P., Pei, Y.-Y., Zhang, X.-Y., Gu, Z.-H., Zhou, Z.-H., Yuan, W.-F., Zhou, J.-J., Zhu, J.-H., & Gao, X.-J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00218-8 · Cited by 540
Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs
Torchilin, V. P., Lukyanov, A. N., Gao, Z., & Papahadjopoulos-Sternberg, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931428100 · Cited by 538
Multifunctional Nanoparticles for Drug Delivery and Molecular Imaging
Bao, G., Mitragotri, S., & Tong, S. (2013) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071812-152409 · Cited by 536
Recent advances in stealth coating of nanoparticle drug delivery systems
Amoozgar, Z., & Yeo, Y. (2012) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1157 · Cited by 528
Kunzmann, A., Andersson, B., Thurnherr, T., Krug, H., Scheynius, A., & Fadeel, B. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2010.04.007 · Cited by 527
Fundamentals and Applications of Controlled Release Drug Delivery
(2012) · Springer eBooks · doi:10.1007/978-1-4614-0881-9 · Cited by 521
Gold Nanoparticles for Nucleic Acid Delivery
Ding, Y., Jiang, Z., Saha, K., Kim, C. S., Kim, S. T., Landis, R. F., & Rotello, V. M. (2014) · Molecular Therapy · doi:10.1038/mt.2014.30 · Cited by 521
Yoo, J.-W., Chambers, E., & Mitragotri, S. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791920496 · Cited by 521
Du, J., Sun, T., Song, W., Wu, J., & Wang, J. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200907210 · Cited by 520
Self-citationLight‐sensitive Intelligent Drug Delivery Systems†
Alvarez‐Lorenzo, C., Bromberg, L., & Concheiro, A. (2009) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2008.00530.x · Cited by 519
Avgoustakis, K. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00530-2 · Cited by 503
Understanding and Overcoming Major Barriers in Cancer Nanomedicine
Nie, S. (2010) · Nanomedicine · doi:10.2217/nnm.10.23 · Cited by 498
Receptor-Mediated Endocytosis of Nanoparticles of Various Shapes
Vácha, R., Martinez-Veracoechea, F. J., & Frenkel, D. (2011) · Nano Letters · doi:10.1021/nl2030213 · Cited by 494
Luminescent Gold Nanoparticles with Efficient Renal Clearance
Zhou, C., Long, M., Qin, Y., Sun, X., & Zheng, J. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201007321 · Cited by 490
Zhu, L., Kate, P., & Torchilin, V. P. (2012) · ACS Nano · doi:10.1021/nn300524f · Cited by 489
State-of-the-art materials for ultrasound-triggered drug delivery
Sirsi, S. R., & Borden, M. A. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.12.010 · Cited by 488
Green synthesis of silver nanoparticles using carob leaf extract and its antibacterial activity
Awwad, A. M., Salem, N. M., & Abdeen, A. O. (2013) · International Journal of Industrial Chemistry · doi:10.1186/2228-5547-4-29 · Cited by 488
Welsher, K., Liu, Z., Daranciang, D., & Dai, H. (2008) · Nano Letters · doi:10.1021/nl072949q · Cited by 486
Yang, Z., Liang, G., Wang, L., & Xu, B. (2006) · Journal of the American Chemical Society · doi:10.1021/ja057412y · Cited by 485
Ruan, G., Agrawal, A., Marcus, A. I., & Nie, S. (2007) · Journal of the American Chemical Society · doi:10.1021/ja074936k · Cited by 483
He, Q., & Shi, J. (2014) · Advanced Materials · doi:10.1002/adma.201303123 · Cited by 482
Contribution of Linker Stability to the Activities of Anticancer Immunoconjugates
Alley, S. C., Benjamin, D. R., Jeffrey, S. C., Okeley, N. M., Meyer, D. L., Sanderson, R. J., & Senter, P. D. (2008) · Bioconjugate Chemistry · doi:10.1021/bc7004329 · Cited by 479
pH-sensitive vesicles, polymeric micelles, and nanospheres prepared with polycarboxylates
Felber, A. E., Dufresne, M.-H., & Leroux, J.-C. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.09.006 · Cited by 478
Silverman, J. A., & Deitcher, S. R. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-012-2042-4 · Cited by 474
Kreuter, J., Ramge, P., Petrov, V., Hamm, S., Gelperina, S. E., Engelhardt, B., Alyautdin, R., von Briesen, H., & Begley, D. J. (2003) · Pharmaceutical Research · doi:10.1023/a:1022604120952 · Cited by 469
Vitamin B12and folate in relation to the development of Alzheimer’s disease
Wang, H.-X., Wahlin, A., Basun, H., Fastbom, J., Winblad, B., & Fratiglioni, L. (2001) · Neurology · doi:10.1212/wnl.56.9.1188 · Cited by 469
Li, J., Huo, M., Wang, J., Zhou, J., Mohammad, J. M., Zhang, Y., Zhu, Q., Waddad, A. Y., & Zhang, Q. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.022 · Cited by 468
Self-citationOh, J. K., Siegwart, D. J., Lee, H.-I., Sherwood, G., Peteanu, L., Hollinger, J. O., Kataoka, K., & Matyjaszewski, K. (2007) · Journal of the American Chemical Society · doi:10.1021/ja069150l · Cited by 467
Enzyme-responsive materials: a new class of smart biomaterials
Ulijn, R. V. (2006) · Journal of Materials Chemistry · doi:10.1039/b601776m · Cited by 467
Quantum dots as a platform for nanoparticle drug delivery vehicle design
Probst, C. E., Zrazhevskiy, P., Bagalkot, V., & Gao, X. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.036 · Cited by 466
Lipid-based systemic delivery of siRNA
Tseng, Y.-C., Mozumdar, S., & Huang, L. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.003 · Cited by 463
In Vivo Molecular Photoacoustic Tomography of Melanomas Targeted by Bioconjugated Gold Nanocages
Kim, C., Cho, E. C., Chen, J., Song, K. H., Au, L., Favazza, C., Zhang, Q., Cobley, C. M., Gao, F., Xia, Y., et al. (2010) · ACS Nano · doi:10.1021/nn100736c · Cited by 462
Light‐Activated Nanoimpeller‐Controlled Drug Release in Cancer Cells
Lu, J., Choi, E., Tamanoi, F., & Zink, J. I. (2008) · Small · doi:10.1002/smll.200700903 · Cited by 462
From Single- to Multi-Target Drugs in Cancer Therapy: When Aspecificity Becomes an Advantage
Giordano, S., & Petrelli, A. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708783503212 · Cited by 457
Peppas, N. A. (1997) · Current Opinion in Colloid & Interface Science · doi:10.1016/s1359-0294(97)80103-3 · Cited by 454
Cell-Penetrating Quantum Dots Based on Multivalent and Endosome-Disrupting Surface Coatings
Duan, H., & Nie, S. (2007) · Journal of the American Chemical Society · doi:10.1021/ja068158s · Cited by 450
Herceptin: mechanisms of action and resistance
Nahta, R., & Esteva, F. J. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.01.041 · Cited by 446
Woodrow, K. A., Cu, Y., Booth, C. J., Saucier-Sawyer, J. K., Wood, M. J., & Mark Saltzman, W. (2009) · Nature Materials · doi:10.1038/nmat2444 · Cited by 438
Porous Hollow Fe3O4 Nanoparticles for Targeted Delivery and Controlled Release of Cisplatin
Cheng, K., Peng, S., Xu, C., & Sun, S. (2009) · Journal of the American Chemical Society · doi:10.1021/ja903300f · Cited by 438
Seymour, L. W., Duncan, R., Strohalm, J., & Kopeček, J. (1987) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820211106 · Cited by 436
Photoregulated Release of Caged Anticancer Drugs from Gold Nanoparticles
Agasti, S. S., Chompoosor, A., You, C.-C., Ghosh, P., Kim, C. K., & Rotello, V. M. (2009) · Journal of the American Chemical Society · doi:10.1021/ja900591t · Cited by 434
Sung, J. H., & Shuler, M. L. (2009) · Lab on a Chip · doi:10.1039/b901377f · Cited by 431
DNA assembly of nanoparticle superstructures for controlled biological delivery and elimination
Chou, L. Y. T., Zagorovsky, K., & Chan, W. C. W. (2014) · Nature Nanotechnology · doi:10.1038/nnano.2013.309 · Cited by 428
Perspectives and opportunities for nanomedicine in the management of atherosclerosis
Lobatto, M. E., Fuster, V., Fayad, Z. A., & Mulder, W. J. M. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3578 · Cited by 423
Acid-degradable polymers for drug delivery: a decade of innovation
Binauld, S., & Stenzel, M. H. (2013) · Chemical Communications · doi:10.1039/c2cc36589h · Cited by 421
Multifunctional dendritic polymers in nanomedicine: opportunities and challenges
Khandare, J., Calderón, M., Dagia, N. M., & Haag, R. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15242d · Cited by 418
Remote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradient
Fritze, A., Hens, F., Kimpfler, A., Schubert, R., & Peschka-Süss, R. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.05.028 · Cited by 416
Structural determinants of glomerular permeability
Deen, W. M., Lazzara, M. J., & Myers, B. D. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.281.4.f579 · Cited by 413
The uptake and intracellular fate of PLGA nanoparticles in epithelial cells
Cartiera, M. S., Johnson, K. M., Rajendran, V., Caplan, M. J., & Saltzman, W. M. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.01.057 · Cited by 412
In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density
Zauner, W., Farrow, N. A., & Haines, A. M. R. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00358-8 · Cited by 411
Proton-Sponge Coated Quantum Dots for siRNA Delivery and Intracellular Imaging
Yezhelyev, M. V., Qi, L., O’Regan, R. M., Nie, S., & Gao, X. (2008) · Journal of the American Chemical Society · doi:10.1021/ja800086u · Cited by 407
Sun, T.-M., Du, J.-Z., Yao, Y.-D., Mao, C.-Q., Dou, S., Huang, S.-Y., Zhang, P.-Z., Leong, K. W., Song, E.-W., & Wang, J. (2011) · ACS Nano · doi:10.1021/nn103349h · Cited by 406
Self-citationMoon, G. D., Choi, S.-W., Cai, X., Li, W., Cho, E. C., Jeong, U., Wang, L. V., & Xia, Y. (2011) · Journal of the American Chemical Society · doi:10.1021/ja200894u · Cited by 405
Thermosensitive liposomes for localized delivery and triggered release of chemotherapy
Ta, T., & Porter, T. M. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.03.036 · Cited by 403
Raynal, I., Prigent, P., Peyramaure, S., Najid, A., Rebuzzi, C., & Corot, C. (2004) · Investigative Radiology · doi:10.1097/01.rli.0000101027.57021.28 · Cited by 403
FePt@CoS2 Yolk−Shell Nanocrystals as a Potent Agent to Kill HeLa Cells
Gao, J., Liang, G., Zhang, B., Kuang, Y., Zhang, X., & Xu, B. (2007) · Journal of the American Chemical Society · doi:10.1021/ja067785e · Cited by 403
Potent antibody drug conjugates for cancer therapy
Senter, P. D. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.03.023 · Cited by 401
Targeted Nanoparticles for Cancer Therapy
Reddy, G. S. N. (2021) · Journal of Bioanalysis & Biomedicine · Cited by 401
Park, C., Kim, H., Kim, S., & Kim, C. (2009) · Journal of the American Chemical Society · doi:10.1021/ja9061085 · Cited by 396
He, Q., Gao, Y., Zhang, L., Zhang, Z., Gao, F., Ji, X., Li, Y., & Shi, J. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.06.066 · Cited by 392
Pandey, R. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg477 · Cited by 388
Pharmacological and clinical evaluation of l-asparaginase in the treatment of leukemia
Narta, U. K., Kanwar, S. S., & Azmi, W. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.07.009 · Cited by 384
Stimuli‐Responsive Materials for Controlled Release of Theranostic Agents
Wang, Y., Shim, M. S., Levinson, N. S., Sung, H., & Xia, Y. (2014) · Advanced Functional Materials · doi:10.1002/adfm.201400279 · Cited by 378
Liu, Y., Wu, D., Zhang, W., Jiang, X., He, C., Chung, T. S., Goh, S. H., & Leong, K. W. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200500042 · Cited by 377
Rae, J. M., Creighton, C. J., Meck, J. M., Haddad, B. R., & Johnson, M. D. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9392-8 · Cited by 374
Role of gemcitabine in cancer therapy
Toschi, L., Finocchiaro, G., Bartolini, S., Gioia, V, & Cappuzzo, F. (2005) · Future Oncology · doi:10.1517/14796694.1.1.7 · Cited by 373
IR-780 dye loaded tumor targeting theranostic nanoparticles for NIR imaging and photothermal therapy
Yue, C., Liu, P., Zheng, M., Zhao, P., Wang, Y., Ma, Y., & Cai, L. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.05.071 · Cited by 372
Evaluation of nanoparticle immunotoxicity
Dobrovolskaia, M. A., Germolec, D. R., & Weaver, J. L. (2009) · Nature Nanotechnology · doi:10.1038/nnano.2009.175 · Cited by 368
Song, C. X., Labhasetwar, V, Murphy, H., Qu, X., Humphrey, W. R., Shebuski, R. J., & Levy, R. J. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(96)01484-8 · Cited by 367
Assessing Nanoparticle Toxicity
Love, S. A., Maurer-Jones, M. A., Thompson, J. W., Lin, Y.-S., & Haynes, C. L. (2012) · Annual Review of Analytical Chemistry · doi:10.1146/annurev-anchem-062011-143134 · Cited by 367
Patel, P. C., Giljohann, D. A., Daniel, W. L., Zheng, D., Prigodich, A. E., & Mirkin, C. A. (2010) · Bioconjugate Chemistry · doi:10.1021/bc1002423 · Cited by 366
Emerging Applications of Phase‐Change Materials (PCMs): Teaching an Old Dog New Tricks
Hyun, D. C., Levinson, N. S., Jeong, U., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201305201 · Cited by 363
Self-citationUV and Near-IR Triggered Release from Polymeric Nanoparticles
Fomina, N., McFearin, C., Sermsakdi, M., Edigin, O., & Almutairi, A. (2010) · Journal of the American Chemical Society · doi:10.1021/ja102595j · Cited by 362
Lipase-Sensitive Polymeric Triple-Layered Nanogel for “On-Demand” Drug Delivery
Xiong, M.-H., Bao, Y., Yang, X.-Z., Wang, Y.-C., Sun, B., & Wang, J. (2012) · Journal of the American Chemical Society · doi:10.1021/ja211279u · Cited by 361
Erosion kinetics of hydrolytically degradable polymers.
Tamada, J. A., & Langer, R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.552 · Cited by 356
Gessner, A., Lieske, A., Paulke, B. R., & Müller, R. H. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00081-4 · Cited by 356
Kim, D.-W., Kim, S.-Y., Kim, H.-K., Kim, S.-W., Shin, S. W., Kim, J. S., Park, K., Lee, M. Y., & Heo, D. S. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm374 · Cited by 356
Tada, H., Higuchi, H., Wanatabe, T. M., & Ohuchi, N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1185 · Cited by 352
Xiao, Z., Ji, C., Shi, J., Pridgen, E. M., Frieder, J., Wu, J., & Farokhzad, O. C. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201204018 · Cited by 351
Does a targeting ligand influence nanoparticle tumor localization or uptake?
Pirollo, K. F., & Chang, E. H. (2008) · Trends in Biotechnology · doi:10.1016/j.tibtech.2008.06.007 · Cited by 347
Ford Versypt, A. N., Pack, D. W., & Braatz, R. D. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.10.015 · Cited by 345
Sentinel Lymph Node Imaging Using Quantum Dots in Mouse Tumor Models
Ballou, B., Ernst, L. A., Andreko, S., Harper, T., Fitzpatrick, J. A. J., Waggoner, A. S., & Bruchez, M. P. (2007) · Bioconjugate Chemistry · doi:10.1021/bc060261j · Cited by 344
Cao, S.-W., Zhu, Y.-J., Ma, M.-Y., Li, L., & Zhang, L. (2008) · The Journal of Physical Chemistry C · doi:10.1021/jp077468+ · Cited by 342
Zucker, D., Marcus, D., Barenholz, Y., & Goldblum, A. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.05.036 · Cited by 340
Zhang, C., Jugold, M., Woenne, E. C., Lammers, T., Morgenstern, B., Mueller, M. M., Zentgraf, H., Bock, M., Eisenhut, M., Semmler, W., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1668 · Cited by 336
Taratula, O., Garbuzenko, O. B., Kirkpatrick, P., Pandya, I., Savla, R., Pozharov, V. P., He, H., & Minko, T. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.06.019 · Cited by 328
Nanoparticle Geometry and Surface Orientation Influence Mode of Cellular Uptake
Herd, H., Daum, N., Jones, A. T., Huwer, H., Ghandehari, H., & Lehr, C.-M. (2013) · ACS Nano · doi:10.1021/nn304439f · Cited by 326
Dinndorf, P. A., Gootenberg, J., Cohen, M. H., Keegan, P., & Pazdur, R. (2007) · The Oncologist · doi:10.1634/theoncologist.12-8-991 · Cited by 324
The Carrier Potential of Liposomes in Biology and Medicine: (Second of Two Parts)
Gregoriadis, G. (1976) · New England Journal of Medicine · doi:10.1056/nejm197609302951406 · Cited by 321
Panyam, J., Williams, D., Dash, A., Leslie‐Pelecky, D., & Labhasetwar, V. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20094 · Cited by 320
Grafted poly-(ethylene glycol) on lipid surfaces inhibits protein adsorption and cell adhesion
Du, H., Chandaroy, P., & Hui, S. W. (1997) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(97)00027-8 · Cited by 319
Functional Mesoporous Silica Nanoparticles for Photothermal‐Controlled Drug Delivery In Vivo
Yan, H., Teh, C., Sreejith, S., Zhu, L., Kwok, A., Fang, W., Ma, X., Nguyen, K. T., Korzh, V., & Zhao, Y. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201203993 · Cited by 317
Li, G. L., Möhwald, H., & Shchukin, D. G. (2013) · Chemical Society Reviews · doi:10.1039/c3cs35517a · Cited by 314
Yu, J., Javier, D., Yaseen, M. A., Nitin, N., Richards-Kortum, R., Anvari, B., & Wong, M. S. (2010) · Journal of the American Chemical Society · doi:10.1021/ja908139y · Cited by 312
Nii, T., & Ishii, F. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.04.029 · Cited by 311
Bernardos, A., Mondragón, L., Aznar, E., Marcos, M. D., Martínez-Máñez, R., Sancenón, F., Soto, J., Barat, J. M., Pérez-Payá, E., Guillem, C., et al. (2010) · ACS Nano · doi:10.1021/nn101499d · Cited by 310
Biocompatibility and drug delivery systems
Kohane, D. S., & Langer, R. (2010) · Chem. Sci. · doi:10.1039/c0sc00203h · Cited by 307
Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers
Caldorera-Moore, M., Guimard, N., Shi, L., & Roy, K. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903579971 · Cited by 304
Mancini, M. C., Kairdolf, B. A., Smith, A. M., & Nie, S. (2008) · Journal of the American Chemical Society · doi:10.1021/ja8040477 · Cited by 295
Hydrotropic polymer micelle system for delivery of paclitaxel
Huh, K. M., Lee, S. C., Cho, Y. W., Lee, J., Jeong, J. H., & Park, K. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.003 · Cited by 291
PRINT: A Novel Platform Toward Shape and Size Specific Nanoparticle Theranostics
Perry, J. L., Herlihy, K. P., Napier, M. E., & DeSimone, J. M. (2011) · Accounts of Chemical Research · doi:10.1021/ar2000315 · Cited by 290
Cohen-Sela, E., Chorny, M., Koroukhov, N., Danenberg, H. D., & Golomb, G. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.09.073 · Cited by 285
In vivo Drug-Linker Stability of an Anti-CD30 Dipeptide-Linked Auristatin Immunoconjugate
Sanderson, R. J., Hering, M. A., James, S. F., Sun, M. M. C., Doronina, S. O., Siadak, A. W., Senter, P. D., & Wahl, A. F. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.843.11.2 · Cited by 285
Assembly of Nanoparticles into Hollow Spheres Using Block Copolypeptides
Wong, M. S., Cha, J. N., Choi, K.-S., Deming, T. J., & Stucky, G. D. (2002) · Nano Letters · doi:10.1021/nl020244c · Cited by 281
Toxicology of Nanomaterials Used in Nanomedicine
Zhao, J., & Castranova, V. (2011) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937404.2011.615113 · Cited by 280
A Theoretical Model for the Margination of Particles within Blood Vessels
Decuzzi, P., Lee, S., Bhushan, B., & Ferrari, M. (2005) · Annals of Biomedical Engineering · doi:10.1007/s10439-005-8976-5 · Cited by 280
Chen, K.-J., Liang, H.-F., Chen, H.-L., Wang, Y., Cheng, P.-Y., Liu, H.-L., Xia, Y., & Sung, H.-W. (2013) · ACS Nano · doi:10.1021/nn304474j · Cited by 279
Strategies for enzyme/prodrug cancer therapy.
Xu, G., & McLeod, H. L. (2001) · PubMed · Cited by 279
Greish, K., Fang, J., Inutsuka, T., Nagamitsu, A., & Maeda, H. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342130-00002 · Cited by 278
Functional Mesoporous Silica Nanoparticles for Photothermal‐Controlled Drug Delivery In Vivo
Yan, H., Teh, C., Sreejith, S., Zhu, L., Kwok, A., Fang, W., Ma, X., Nguyen, K. T., Korzh, V., & Zhao, Y. (2012) · Angewandte Chemie · doi:10.1002/ange.201203993 · Cited by 278
Cheng, L., He, W., Gong, H., Wang, C., Chen, Q., Cheng, Z., & Liu, Z. (2013) · Advanced Functional Materials · doi:10.1002/adfm.201301045 · Cited by 277
Best Practices in Cancer Nanotechnology: Perspective from NCI Nanotechnology Alliance
Zamboni, W. C., Torchilin, V., Patri, A. K., Hrkach, J., Stern, S., Lee, R., Nel, A., Panaro, N. J., & Grodzinski, P. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2938 · Cited by 275
Biomedical nanoparticle carriers with combined thermal and magnetic responses
Liu, T.-Y., Hu, S.-H., Liu, D.-M., Chen, S.-Y., & Chen, I.-W. (2009) · Nano Today · doi:10.1016/j.nantod.2008.10.011 · Cited by 273
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.023 · Cited by 270
Nanoparticle delivery systems for cancer therapy: advances in clinical and preclinical research
Egusquiaguirre, S. P., Igartua, M., Hernández, R. M., & Pedraz, J. L. (2012) · Clinical and Translational Oncology · doi:10.1007/s12094-012-0766-6 · Cited by 268
Factors affecting microencapsulation of drugs in liposomes
Kulkarni, S. B., Betageri, G. V., & Singh, M. (1995) · Journal of Microencapsulation · doi:10.3109/02652049509010292 · Cited by 261
Multi-Target Drugs: The Trend of Drug Research and Development
Lu, J.-J., Pan, W., Hu, Y.-J., & Wang, Y.-T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040262 · Cited by 259
Doxorubicin physical state in solution and inside liposomes loaded via a pH gradient
Li, X., Hirsh, D. J., Cabral-Lilly, D., Zirkel, A., Gruner, S. M., Janoff, A. S., & Perkins, W. R. (1998) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00175-8 · Cited by 259
Moghimi, S. M., Muir, I. S., Illum, L., Davis, S. S., & Kolb-Bachofen, V (1993) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(93)90137-e · Cited by 259
Scorilas, A., Karameris, A., Arnogiannaki, N., Ardavanis, A., Bassilopoulos, P., Trangas, T., & Talieri, M. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1810 · Cited by 258
A polymer library approach to suicide gene therapy for cancer
Anderson, D. G., Peng, W., Akinc, A., Hossain, N., Kohn, A., Padera, R., Langer, R., & Sawicki, J. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407218101 · Cited by 258
Light‐Responsive Biomaterials: Development and Applications
Katz, J. S., & Burdick, J. A. (2010) · Macromolecular Bioscience · doi:10.1002/mabi.200900297 · Cited by 257
Role of Nanoparticle Geometry in Endocytosis: Laying Down to Stand Up
Huang, C., Zhang, Y., Yuan, H., Gao, H., & Zhang, S. (2013) · Nano Letters · doi:10.1021/nl402628n · Cited by 257
Self-citationNanoparticle–aptamer bioconjugates for cancer targeting
Farokhzad, O. C., Karp, J. M., & Langer, R. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.3.311 · Cited by 256
Polymer micelles with cross-linked polyanion core for delivery of a cationic drug doxorubicin
Kim, J. O., Kabanov, A. V., & Bronich, T. K. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.04.019 · Cited by 255
Spatiotemporal controlled delivery of nanoparticles to injured vasculature
Chan, J. M., Zhang, L., Tong, R., Ghosh, D., Gao, W., Liao, G., Yuet, K. P., Gray, D., Rhee, J.-W., Cheng, J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914585107 · Cited by 253
A new approach towards acid sensitive copolymer micelles for drug delivery
Gillies, E. R., & Fréchet, J. M. J. (2003) · Chem. Commun. · doi:10.1039/b304251k · Cited by 252
Wang, M., Alberti, K., Sun, S., Arellano, C. L., & Xu, Q. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201311245 · Cited by 251
Yuan, Q., Zhang, Y., Chen, T., Lu, D., Zhao, Z., Zhang, X., Li, Z., Yan, C.-H., & Tan, W. (2012) · ACS Nano · doi:10.1021/nn3018365 · Cited by 251
Self-citationMu, L., & Feng, S.-S. (2003) · Pharmaceutical Research · doi:10.1023/b:pham.0000003387.15428.42 · Cited by 250
Applications of nanomaterials inside cells
Gao, J., & Xu, B. (2009) · Nano Today · doi:10.1016/j.nantod.2008.10.009 · Cited by 249
Das, M., Sanson, N., Fava, D., & Kumacheva, E. (2007) · Langmuir · doi:10.1021/la061596s · Cited by 249
Sun, T.-M., Du, J.-Z., Yan, L.-F., Mao, H.-Q., & Wang, J. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.07.036 · Cited by 248
Self-citationDifferent strategies to overcome multidrug resistance in cancer
Saraswathy, M., & Gong, S. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.06.004 · Cited by 248
A Temperature‐Sensitive Drug Release System Based on Phase‐Change Materials
Choi, S., Zhang, Y., & Xia, Y. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201004057 · Cited by 247
Self-citationCharacterization of liposomal systems containing doxorubicin entrapped in response to pH gradients
Mayer, L. D., Tai, L. C. L., Bally, M. B., Mitilenes, G. N., Ginsberg, R. S., & Cullis, P. R. (1990) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(90)90091-2 · Cited by 245
Dendrimeric micelles for controlled drug release and targeted delivery
Ambade, A. V., Savariar, E. N., & Thayumanavan, S. (2005) · Molecular Pharmaceutics · doi:10.1021/mp050020d · Cited by 245
Involvement of cathepsins in the invasion, metastasis and proliferation of cancer cells
Nomura, T., & Katunuma, N. (2005) · The Journal of Medical Investigation · doi:10.2152/jmi.52.1 · Cited by 244
Mamot, C., Ritschard, R., Wicki, A., Stehle, G., Dieterle, T., Bubendorf, L., Hilker, C., Deuster, S., Herrmann, R., & Rochlitz, C. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70476-x · Cited by 244
Ultrasound‐Triggered Smart Drug Release from a Poly(dimethylsiloxane)– Mesoporous Silica Composite
Kim, H. ‐., Matsuda, H., Zhou, H., & Honma, I. (2006) · Advanced Materials · doi:10.1002/adma.200600387 · Cited by 239
Xia, X., Yang, M., Wang, Y., Zheng, Y., Li, Q., Chen, J., & Xia, Y. (2012) · ACS Nano · doi:10.1021/nn2038516 · Cited by 239
Self-citationControl of tumour vascular permeability
Baban, D. F., & Seymour, L. W. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00003-9 · Cited by 237
Kato, K., Chin, K., Yoshikawa, T., Yamaguchi, K., Tsuji, Y., Esaki, T., Sakai, K., Kimura, M., Hamaguchi, T., Shimada, Y., et al. (2012) · Investigational New Drugs · doi:10.1007/s10637-011-9709-2 · Cited by 237
Gold nanocages as contrast agents for spectroscopic optical coherence tomography
Cang, H., Sun, T., Li, Z.-Y., Chen, J., Wiley, B. J., Xia, Y., & Li, X. (2005) · Optics Letters · doi:10.1364/ol.30.003048 · Cited by 234
Self-citationA pH-sensitive doxorubicin prodrug based on folate-conjugated BSA for tumor-targeted drug delivery
Du, C., Deng, D., Shan, L., Wan, S., Cao, J., Tian, J., Achilefu, S., & Gu, Y. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.041 · Cited by 230
Weiss, G. J., Chao, J., Neidhart, J. D., Ramanathan, R. K., Bassett, D., Neidhart, J. A., Choi, C. H. J., Chow, W., Chung, V., Forman, S. J., et al. (2013) · Investigational New Drugs · doi:10.1007/s10637-012-9921-8 · Cited by 230
Hong, R. L., Huang, C. J., Tseng, Y., Pang, V. F., Chen, S.-T., Liu, J. J., & Chang, F. (1999) · PubMed · Cited by 227
Zolot, R. S., Basu, S., & Million, R. P. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3980 · Cited by 227
Zheng, X., Zhou, F., Wu, B., Chen, W. R., & Xing, D. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200526m · Cited by 226
Defining the drug incorporation properties of PLA–PEG nanoparticles
Govender, T. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00375-6 · Cited by 225
Photoactivated nanomaterials for biomedical release applications
Sortino, S. (2012) · J. Mater. Chem. · doi:10.1039/c1jm13288a · Cited by 225
L�ck, M., Paulke, B.-R., Schr�der, W., Blunk, T., & M�ller, R. H. (1998) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(19980305)39:3<478::aid-jbm19>3.0.co;2-6 · Cited by 225
Al-Ahmady, Z. S., Al-Jamal, W. T., Bossche, J. V., Bui, T. T., Drake, A. F., Mason, A. J., & Kostarelos, K. (2012) · ACS Nano · doi:10.1021/nn302148p · Cited by 224
Tunable Self-Assembly of Genetically Engineered Silk–Elastin-like Protein Polymers
Xia, X.-X., Xu, Q., Hu, X., Qin, G., & Kaplan, D. L. (2011) · Biomacromolecules · doi:10.1021/bm201165h · Cited by 223
Preclinical Efficacy of the Camptothecin-Polymer Conjugate IT-101 in Multiple Cancer Models
Schluep, T., Hwang, J., Cheng, J., Heidel, J. D., Bartlett, D. W., Hollister, B., & Davis, M. E. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1566 · Cited by 222
Bae, Y., Fukushima, S., Harada, A., & Kataoka, K. (2003) · Angewandte Chemie · doi:10.1002/ange.200250653 · Cited by 221
Dailey, L. A., Jekel, N., Fink, L., Gessler, T., Schmehl, T., Wittmar, M., Kissel, T., & Seeger, W. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.01.016 · Cited by 220
Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor
Li, Y., Wang, J., Wientjes, M. G., & Au, J. L.-S. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.04.006 · Cited by 219
Hatakeyama, H., Akita, H., Ito, E., Hayashi, Y., Oishi, M., Nagasaki, Y., Danev, R., Nagayama, K., Kaji, N., Kikuchi, H., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.045 · Cited by 216
You, J., Zhang, R., Xiong, C., Zhong, M., Melancon, M., Gupta, S., Nick, A. M., Sood, A. K., & Li, C. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1003 · Cited by 214
van Vlerken, L. E., Duan, Z., Seiden, M. V., & Amiji, M. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1648 · Cited by 214
Tagami, T., Foltz, W. D., Ernsting, M. J., Lee, C. M., Tannock, I. F., May, J. P., & Li, S.-D. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.029 · Cited by 213
Small-molecule delivery by nanoparticles for anticancer therapy
Chen, Z. (. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.08.001 · Cited by 212
Engineered nanomaterial uptake and tissue distribution: from cell to organism
Huwyler, J., Kettiger, H., Schipanski, A., & Wick, P. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s49770 · Cited by 210
Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges
Zhou, J., Shum, K.-T., Burnett, J., & Rossi, J. (2013) · Pharmaceuticals · doi:10.3390/ph6010085 · Cited by 205
Yokoyama, M., Satoh, A., Sakurai, Y., Okano, T., Matsumura, Y., Kakizoe, T., & Kataoka, K. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00054-6 · Cited by 203
Synthesis of Linear, β-Cyclodextrin-Based Polymers and Their Camptothecin Conjugates
Cheng, J., Khin, K. T., Jensen, G. S., Liu, A., & Davis, M. E. (2003) · Bioconjugate Chemistry · doi:10.1021/bc0340924 · Cited by 203
Nanopharmacy: Inorganic nanoscale devices as vectors and active compounds
Rivera Gil, P., Hühn, D., del Mercato, L. L., Sasse, D., & Parak, W. J. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.01.009 · Cited by 202
Witzig, T. E., Vukov, A. M., Habermann, T. M., Geyer, S., Kurtin, P. J., Friedenberg, W. R., White, W. L., Chalchal, H. I., Flynn, P. J., Fitch, T. R., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.052 · Cited by 200
Nanoparticle clearance is governed by Th1/Th2 immunity and strain background
Jones, S. W., Roberts, R. A., Robbins, G. R., Perry, J. L., Kai, M. P., Chen, K., Bo, T., Napier, M. E., Ting, J. P. Y., DeSimone, J. M., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66895 · Cited by 197
Chang, Y., Liao, P., Sheu, H., Tseng, Y., Cheng, F., & Yeh, C. (2012) · Advanced Materials · doi:10.1002/adma.201200785 · Cited by 193
Targeting gold nanocages to cancer cells for photothermal destruction and drug delivery
Cobley, C. M., Au, L., Chen, J., & Xia, Y. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903571614 · Cited by 191
Light-Activated Content Release from Liposomes
Leung, S. J., & Romanowski, M. (2012) · Theranostics · doi:10.7150/thno.4847 · Cited by 189
Antibody–drug conjugates for cancer: poised to deliver?
Hughes, B. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3270 · Cited by 188
Tam, J. M., Tam, J. O., Murthy, A., Ingram, D. R., Ma, L. L., Travis, K., Johnston, K. P., & Sokolov, K. V. (2010) · ACS Nano · doi:10.1021/nn9015746 · Cited by 186
Pharmaceutical applications of dendrimers: promising nanocarriers for drug delivery
Cheng, Y. (2008) · Frontiers in Bioscience · doi:10.2741/2774 · Cited by 184
Intracellular delivery of core–shell fluorescent silica nanoparticles
Fuller, J. E., Zugates, G. T., Ferreira, L. S., Ow, H. S., Nguyen, N. N., Wiesner, U. B., & Langer, R. S. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.11.025 · Cited by 183
In vivo assembly of nanoparticle components to improve targeted cancer imaging
Perrault, S. D., & Chan, W. C. W. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001367107 · Cited by 181
Research works printed but not linked: 30
- Aruna U., 2013, Inter. J. Inn. Pharm. Res., 4, 318
- Langer R., 1998, Nature, 392, 5
- Petre C. E., 2007, Int. J. Nanomed., 2, 277
- Lao J., 2013, J. Drug Delivery, 456409
- Saif M. W., 2007, JOP, 8, 166
- Matsumura Y., 1986, Cancer Res., 46, 6387
- 10.1002/1097-0142(20011115)92:10<2592::AID-CNCR1612>3.0.CO;2-4 · doi:10.1002/1097-0142(20011115)92:10<2592::aid-cncr1612>3.0.co;2-4
- Xu G., 2001, Clin. Cancer Res., 7, 3314
- 10.1016/j.addr.2012.09.008 · doi:10.1016/j.addr.2012.09.008 · Paper page
- Pundir S., 2013, Int. J. Drug Res. Technol., 3, 12
- 10.1021/jp077468 · doi:10.1021/jp077468
- Mohanraj V. J., 2006, J. Pharm. Res., 5, 561
- Ma Y. D., 2011, Int. J. Nanomed., 6, 2679
- 10.1002/(SICI)1097-4636(199908)46:2<236::AID-JBM13>3.0.CO;2-F · doi:10.1002/(sici)1097-4636(199908)46:2<236::aid-jbm13>3.0.co;2-f
- Krishna R., 2000, Eur. J. Cancer Sci., 11, 265
- Kettiger H., 2013, Int. J. Nanomed., 8, 3255
- Yuan F., 1995, Cancer Res., 55, 3752
- Jain R. K., 1987, Cancer Res., 47, 3039
- 10.1021/nn900002m · DOI · Paper page
- Chidambaram M., 2012, Int. J. Pharm. Sci., 2, 117
- 10.1039/C1CS15237H · DOI · Paper page
- 10.1038/nnano.2007.223 · DOI · Paper page
- Mohanraj V. J., 2006, Trop. J. Pharm. Res., 5, 561
- Hong R. L., 1999, Clin. Cancer Res., 5, 3645
- Shamsipour F., 2009, Avicenna J. Med. Biotechnol., 1, 27
- Park J. W., 2002, Clin. Cancer Res., 8, 1172
- Uppada S. B., 2014, Int. J. Nanomed., 9, 43
- Bangham A. D., 1965, J. Mol. Biol., 13, 227
- Mueller C., 1994, Methods Cell Sci., 16, 183
- 10.1016/j.cbpa.2005.10.005 · DOI
Cited by
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors
Din, F. U., Aman, W., Ullah, I., Qureshi, O. S., Mustapha, O., Shafique, S., & Zeb, A. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s146315 · Cited by 1,577
“A number of nanocarrier-based products have been approved for the treatment of various tumors, and many others are in different phases of clinical trials.(4) In the current review, we first discussed features of different types of nanocarriers (organic, inorganic and hybrid) along with their relevance in cancer therap…”
BackgroundInfluentialLiposomes: Structure, composition, types, and clinical applications
Nsairat, H., Khater, D., Sayed, U., Odeh, F., Al Bawab, A., & Alshaer, W. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09394 · Cited by 1,561
“Liposomes are spherical lipid vesicles (usually 50–500 nm in diameter particle size) composed of one or more lipid bilayers, as a result of emulsifying natural or synthetic lipids in an aqueous medium [12, 13] (Figure 1).”
BackgroundNanoparticle–liver interactions: Cellular uptake and hepatobiliary elimination
Zhang, Y.-N., Poon, W., Tavares, A. J., McGilvray, I. D., & Chan, W. C. W. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.020 · Cited by 1,349
“020 intended target and are sequestered by the liver and spleen (if N6 nm) or eliminated though the kidney (if b6 nm) after administration into the body [2,4].”
BackgroundMethodSelf-citationChallenges and strategies in anti-cancer nanomedicine development: An industry perspective
Hare, J. I., Lammers, T., Ashford, M. B., Puri, S., Storm, G., & Barry, S. T. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.025 · Cited by 1,214
Gold Nanomaterials at Work in Biomedicine
Yang, X., Yang, M., Pang, B., Vara, M., & Xia, Y. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00193 · Cited by 1,162
Self-citation
Metadata
- Authors
- Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y.
- Affiliations
- Georgia Institute of Technology (US)
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2014-10-07
- Volume
- 53
- Issue
- 46
- Pages
- 12320-12364
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W2134726513
- Cited by
- 2,164
- References
- 578
- Citations by year
- 2026: 57 · 2025: 146 · 2024: 163 · 2023: 153 · 2022: 209 · 2021: 200 · 2020: 221 · 2019: 237 · 2018: 257 · 2017: 230 · 2016: 180 · 2015: 109 · 2014: 2
- FWCI
- 11.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Angewandte Chemie International Edition (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- engineered nanoparticles, drug delivery, cancer therapy, targeted drug delivery, enhanced permeability and retention effect, pH-responsive delivery, tumor-targeting ligands, tissue distribution, circulation half-life, immunogenicity, combination therapy, multidrug resistance, contrast media, theranostics, nanoparticle surface modification
- MeSH terms
- Animals, Antineoplastic Agents, Delayed-Action Preparations, Humans, Neoplasms, Drug Delivery Systems, Nanotechnology, Nanomedicine, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.